Skip to main content
UNC Lineberger Comprehensive Cancer Center

Publications

Key to Role on Publications

* Leader for conception, design, data analysis and writing of article/chapter

^ Co-investigator, and contributor to concept and writing

#   Principal investigator of project and mentor to first author

** Mentor to first author

‡ Medical Student, + Resident, ~ Fellow

In the News

Book Chapters

  1. Boggess, JF and Bae-Jump, VL^, Cervical Neoplasia, Netter’s Internal Medicine 2nd Edition, Saunders Elsevier, 2009, 606-613.
  2. Bae-Jump, VL*, Skinner, EN, Sakaguchi, B and Carney, ME, Vulvar Cancer, Gynecologic Oncology, Landes Bioscience, 2009, 181-196.
  3. Mendivil, A~ and Bae-Jump, VL#, Germ Cell Tumors of the Ovary, Gynecologic Cancer Management, Wiley-Blackwell, 2009, 150-162.
  4. Clark, LH~ and Bae-Jump, VL#, Metformin as Adjuvant Therapy in Ovarian and Endometrial Cancers, Energy Balance and Cancer: Focus on Gynecologic Malignancies, Springer, November 2017, 279-304

Refereed Papers/Articles

  1. Anderson C, Lund JL, Park J, Brewster W, Bae-Jump V^, Olshan AF, Nichols HB. Adverse Urinary System Outcomes among Older Women with Endometrial Cancer. Cancer Epidemiol Biomarkers Prev. 2022 Jul 1;31(7):1508. PMID: 35775217.
  2. Anderson C, Olshan A, Bae-Jump V^, Park J, Brewster W, Kent E, Nichols HB. Falls, walking or balance problems, and limitations in activities of daily living (ADLs) among older endometrial cancer survivors. Support Care Cancer. 2022 Jul;30(7):6339-6351. PMID: 35477811.
  3. Brewster WR, Burkett WC, Ko EM, Bae-Jump V^, Nicole McCoy A, Keku TO. An evaluation of the microbiota of the upper reproductive tract of women with and without epithelial ovarian cancer. Gynecol Oncol Rep. 2022 Jun 10;42:101017. PMID: 35754560
  4. Buckingham L~, Hao T, O’Donnell J, Zhao Z, Zhang X, Fan Y, Sun W, Zhang Y, Suo H, Secord AA, Zhou C, Bae-Jump V#, Ipatasertib, an oral AKT inhibitor, inhibits cell proliferation and migration, and induces apoptosis in serous endometrial cancer. Am J Cancer Res. 2022 Jun 15;12(6):2850-2862. eCollection 2022.PMID: 35812065.
  5. Archibald, SJ, Hisada, Y, Bae-Jump, VL^, Mackman, N. Evaluation of a new bead-based assay to measure levels of human tissue factor antigen in extracellular vesicles in plasma. Res Pract Thromb Haemost. 2022 Mar 4;6(2):e12677. PMID: 35284777.
  6. Fan, Y, Wang, J, Fang, Z, Pierce, SR, West, L, Staley, A, Tucker, K, Yin, Y, Sun, W, Kong, W, Prabhu, V, Allen, JE, Zhou, C, Bae-Jump, VL. Anti-Tumor and Anti-Invasive Effects of ONC201 on Ovarian Cancer Cells and a Transgenic Mouse Model of Serous Ovarian Cancer. Front Oncol. 2022 Mar 17;12:789450. PMID: 35372029.
  7. Tucker, K~, Yin, Y, Staley, SA, Zhao, Z, Fang, Z, Fan, Y, Zhang, X, Suo, H, Sun, W, Prabhu, VV, Allen, JE, Zhou, C, Bae-Jump, VL#. ONC206 has anti-tumorigenic effects in human ovarian cancer cells and in a transgenic mouse model of high-grade serous ovarian cancer. Am J Cancer Res. 2022 Feb 15;12(2):521-536. PMID: 35261784.
  8. Hawkins, GM~, Burkett, WC, McCoy, AN, Nichols, HB, Olshan, AF, Broaddus, R, Merker, JD, Weissman, B, Brewster, WR, Roach, J, Keku, TO, Bae-Jump, V#. Differences in the microbial profiles of early stage endometrial cancers between Black and White women. Gynecol Oncol. 2022 Mar 8:S0090-8258(22)00142-1. PMID: 35277280.
  9. Regner MJ, Wisniewska K, Garcia-Recio S, Thennavan A, Mendez-Giraldez R, Malladi VS, Hawkins G, Parker JS, Perou CM, Bae-Jump VL^, Frano HL. A multi-omic single-cell landscape of human gynecologic malignancies. Mol Cell. 2021 Dec 2;81(23):4924-4941. PMID: 34739872.
  10. Staley A~, Tucker K, Yin Y, Zhang X, Fan Y, Zhang Y, Fang Z, Sun W, Suo H Zhao X, Zhao Z, Prabhu VV, Allen JE, Zhou C, Bae-Jump VL#, Highly potent dopamine receptor D2 antagonist ONC206 demonstrates anti-tumorigenic activity in endometrial cancer, Am J Cancer Res 2021 Nov 15;11(11):5374-5387. PMID: 34873466.
  11. Cobb LP, Siamakpour-Reihani S, Zhang D, Qin X, Owzar K, Zhou C, Conrads TP, Maxwell GL, Darcy KM, Bateman NW, Litzi T, Bae-Jump V^, Secord AA. Obesity and altered angiogenic-related gene expression in endometrial cancer. Gynecol Oncol. 2021 Nov;163(2):320-326. PMID: 34538531.
  12. Roque DR, Zhang L, Wysham WZ, Sun H, Yin Y, Livingston JN, Batchelor KW, Zhou Z, Bae-Jump VL#, The Effects of NT-1044, a Novel AMPK Activator, on Endometrial Cancer Cell Proliferation, Apoptosis, Cell Stress and In Vivo Tumor Growth, Front Oncol 2021 Aug 5;11:690435. PMID: 34422646.
  13. Xu G, Kong W, Fang Z, Fan Y, Yin Y, Sullivan SA, Tran AQ, Clark LH, Sun W, Hao T, Zhao L, Zho C, Bae-Jump VL#. Asparagus officinalis Exhibits Anti-Tumorigenic and Anti-Metastatic Effects in Ovarian Cancer. Front Oncol. 2021 July 14;11:688461. PMID: 34336674.
  14. Mysona DP#, Ghamande S, She JX, Tran L, Tran P, Rungruang BJ, Chan JK, Bae-Jump V^, Gehrig P. Are There Survival Differences Between Women with Equivalent Residual Disease After Interval Cytoreductive Surgery Compared with Primary Cytoreductive Surgery for Advanced Ovarian and Peritoneal Cancer? Ann Surg Oncol. 2021 Jul;28(7):3605-3615. PMID: 33155151.
  15. Anderson C, Bae-Jump VL^, Broaddus RR, Olshan AF, Nichols HB. Long-term Patterns of Excess Mortality among Endometrial Cancer Survivors. Cancer Epidemiol Biomarkers Prev. 2021 Jun;30(6):1079-1088. PMID: 33737298.
  16. Tran A, Sullivan S, Chan LL, Yin Y, Sun W, Fang Z, Dugar S, Zhou C, Bae-Jump V#, SPR965, a Dual PI3K/mTOR Inhibitor, as a Targeted Therapy in Ovarian Cancer, Front Oncol 2021 Feb 15;10:624498. PMID: 33659215
  17. Sullivan SA~, Hawkins G, Zhao X, Jo H, Hayes N, Deng X, Bandyopadhyay D, Bae-Jump VL, Rossi EC. Genomic profiling of endometrial cancer and relationship with volume of endometrial cancer disease spread. Gynecol Oncol Rep. 2021 Feb 9;36:100720. PMID: 33732849.
  18. Pierce SR~, Fang Z, Yin Y, West L, Asher M, Hao T, Zhang X, Tucker K, Staley A, Fan Y, Sun W, Moore DT, Xu C, Tsai YH, Parker J, Prabhu VV, Allen JE, Lee D, Zhou C, Bae-Jump V#, Targeting dopamine receptor D2 as a novel therapeutic strategy in endometrial cancer. J  Exp Clin Cancer Res. 2021 Feb 8;40(1):61. PMID: 33557912 Free PMC article.
  19. West L~, Yin Y, Pierce SR, Fang Z, Fan Y, Sun W, Tucker K, Staley A, Zhou C, Bae-Jump V#, Docosahexaenoic acid (DHA), an omega-3 fatty acid, inhibits tumor growth and metastatic potential of ovarian cancer. Am J Cancer Res. 2020 Dec 1;10(12):4450-4463. PMID: 33415010.
  20. Zhang Y‡, Huang Y, Yin Y, Fan Y, Sun W, Zhao X, Tucker K, Staley A, Paraghamian S , Hawkins G, Prabhu V, Allen JE, Zhou C, Bae-Jump VL#, ONC206, an Imipridone Derivative, Induces Cell Death Through Activation of the Integrated Stress Response in Serous Endometrial Cancer In Vitro, Front Oncol, 2020 Oct 20;10:577141. PMID: 33194693.
  21. Mysona DP+,  Ghamande S , She  JX, Tran  L, Tran  P, Rungruang  BJ, Chan  JK, Bae-Jump V^, Gehrig PA, Are There Survival Differences Between Women with Equivalent Residual Disease After Interval Cytoreductive Surgery Compared with Primary Cytoreductive Surgery for Advanced Ovarian and Peritoneal Cancer? Ann Surg Oncol. 2020 Nov 5. Online ahead of print. PMID: 33155151.
  22. AlHilli M, Bae-Jump V#, Diet and gut microbiome interactions in gynecologic cancer. Gynecol Oncol. 2020 Nov;159(2):299-308. PMID: 32933758
  23. Zhao X, Kong W, Tucker K, Staley A, Fan Y, Sun W, Yin Y, Huang Y, Fang Z, Wang J, Sen S, Dugar S, Zhou C, Bae-Jump VL#. SPR064, a pro-drug of paclitaxel, has anti-tumorigenic effects in endometrial cancer cell lines and mouse models. Am J Transl Res. 2020 Aug 15;12(8):4264-4276. PMID: 32913503
  24. Bae-Jump, VL*. Invited Lead Editorial: Unraveling the mystery of clear cell endometrial cancer, Gynecol Oncol, 2020 Jul;158(1):1-2. PMID:  32580885
  25. Bae-Jump, VL^ and Levine, DA. Comment: A Catalogue of Cancer-Driving Mutations in Healthy Tissue, Nature, 2020 Apr;580(7805):595-596. PMID: 32322030
  26. Mills KA, Joshi TV, West L, Kuznicki M, Kent L, Hokenstad AN, Cripe JC, Woolfolk C, Senter L, Bakkum-Gamez JN, Wenham RM, Cohn DE, Bae-Jump VL^, Thaker PH. Is Hormonal Therapy After Risk-Reducing Salpingo-Oophorectomy Associated With an Increased Risk of Malignancy in Pathogenic Variant Carriers? Gynecol Oncol., 2020 Mar 3:S0090-8258(20)30179-7. PMID: 32143914
  27. Cuevas, IC, Sahoo, SS, Kumar, A, Zhang, H, Westcott, J, Aguilar, M, Cortez, JD, Sullivan, SA, Xing, C, Hayes, DN, Brekken, RA, Bae-Jump, VL^, Castrillon DH. Fbxw7 is a driver of uterine carcinosarcoma by promoting epithelial-mesenchymal transition, Proc Natl Acad Sci U S A, 2019, Dec 17;116(51):25880-25890. PMID:31772025
  28. Hui, G, Han, J, Zhang, L, Clark, LH, Yin, Y, Fang, Z, Sun, W, Gilliam, T, Lee, D, Makowski, L, Zhou, C, Bae-Jump, VL#, Reversal of Obesity-Driven Aggressiveness of Endometrial Cancer by Metformin, American Journal of Cancer Research, 2019, Oct 1;9(10):2170-2193. PMID: 31720081
  29. Bateman, N, Hope, E, Teng, P, Hood, B, Zhou, M, Wilson, K, Ao, W, Tommarello, D, Conrads, KA, Oliver, J, Darcy, KM, Hamilton, CA, Casablanca, Y, Maxwell, GL, Bae-Jump, VL*, and Conrads, TP, Jupiter Microtubule Associated Homolog 1 (JPT1): a predictive and pharmacodynamic biomarker of metformin response in endometrial cancers, Cancer Medicine, 2020, Feb;9(3):1092-1103. PMID: 31808620
  30. Grace, MR~, Dotters-Katz, SK, Zhou C, Manuck, T, Boggess, K, Bae-Jump, VL#, Effect of a High-Fat Diet and Metformin on Placental mTOR Signaling in Mice, AJP Rep, 2019, Apr;9(2):e138-e143. PMID: 30972229
  31. Fang, Z, Wang, J, Clark, LH, Sun, W, Yin, Y, Kong, W, Pierce, SR, West, L, Sullivan, SA, Tran, AQ, Prabhu, VV, Zhou, C, Bae-Jump, VL#, ONC201 demonstrates anti-tumorigenic and anti-metastatic activity in uterine serous carcinoma in vitro, Am J Cancer Res, 2018, Aug 1;8(8):1551-1563, PMID: 30210923
  32. Xu, G, Fang, Z, Clark, LH, Sun, W, Yin, Y, Zhang, R, Sullivan, SA, Tran, AQ, Kong, W, Wang,, J, Zhou C, Bae-Jump, VL#, Topiramate exhibits anti-tumorigenic and metastatic effects in ovarian cancer cells, Am J Transl Res, 2018, Jun 15;10(6):1663-1676, PMID: 30018708
  33. Vora, NL, Grace, MR, Smeester, L, Dotters-Katz, SK, Fry, RC, Bae-Jump, V^, Boggess, K, Targeted Multiplex Gene Expression Profiling to Measure High-Fat Diet and Metformin Effects on Fetal Gene Expression in a Mouse Model, Reprod Sci, 2019, May; 26(5):683-689. PMID: 29976116
  34. Malloy, KM, Wang, J, Clark, LH, Fang, Z, Sun, W, Yin, Y, Kong, W, Zhou, C, Bae-Jump VL#, Novasoy and genistein inhibit endometrial cancer cell proliferation through disruption of the AKT/mTOR and MAPK signaling pathways, Am J Transl Res, 2018, Mar 15;10(3):784-795. PMID:29636868
  35. Jones HM, Fang Z, Sun W, Clark LH, Stine JE, Tran AQ, Sullivan SA, Gilliam TP, Zhou C, Bae-Jump VL#, Atorvastatin exhibits anti-tumorigenic and anti-metastatic effects in ovarian cancer in vitro. Am J Cancer Res, 2017, Dec 1;7(12):2478-2490. PMID:29312801
  36. Jackson, AL~, Sun, W, Kilgore, J, Guo, H, Jones, HM, Gilliam, TP, Gehrig, PA, Zhou, Z, Bae-Jump, VL#, Phenformin has anti-tumorigenic effects in human ovarian cancer cells and in an orthotopic mouse model of serous ovarian cancer. Oncotarget, 2017, Oct 24;8(59):100113-100127. PMID: 29245964
  37. Han, J, Wysham, WZ, Zhong, Y, Guo, H, Zhang, L, Malloy, KM, Dickens, HK, Huh, G, Lee, D, Makowski, L, Zhou, C, Bae-Jump, VL#, Increased efficacy of metformin corresponds to differential metabolic effects in the ovarian tumors from obese versus lean mice. Oncotarget, 2017, Sep 8;8(67):110965-110982. PMID: 29340030
  38. MacKay, HJ, Levine, DA, Bae-Jump, VL^, Bell, DW, McAlpine, JN, Santin, A, Fleming, GF, Mutch, DG, Nephew, KP, Wentzensen, N, Goodfellow, PJ, Dorigo, O, Nijman, HW, Broaddus, R, Kohn, EC, Moving forward with actionable therapeutic targets and opportunities in endometrial cancer: NCI clinical trials planning meeting report on identifying key genes and molecular pathways for targeted endometrial cancer trials. Oncotarget, 2017, Aug: 8 (48): 84579-84594.
  39. Soper, S, Witek, M, Wang, H, Kamande, J, Jackson, J, Pullagurla, S, Hupert, M, Usary, J, Wysham, W, Hilliard, D, Montogomery, S, Bae-Jump, V^, Carey, L, Gehrig, P, Milowsky, M, Perou, C, Soper, J, Whang, Y, Yeh, JJ, Martin, G, Aufforth, R, Discrete Microfluidics for the Isolation of Circulating Tumor Cell Subpopulations Targeting Fibroblast Activation Protein alpha and Epithelial Cell Adhesion Molecule. Nature Precision Oncology, 2017, July, 1 (24):1-11.
  40. Sun, S, Yin, Y, Clark, LH, Sun, W, Sullivan, SA, Tran, AQ, Han, J, Zhang, L, Guo, H, Madugu, E, Pan, T, Jackson, AL, Kilgore, J, Jones, HM, Gilliam, T,  Zhou, C, Bae-Jump, VL#, Dual inhibition of glycolysis and glutaminolysis as a therapeutic strategy in the treatment of ovarian cancer. Oncotarget, 2017, Jun 29; 8 (38):63551-63561. PMID: 28969010
  41. Wang, X, Arceci, A, Bird, K, Mills, CA, Choudhury, R, Kernan, JL, Zhou, C, Bae-Jump, V^, Bowers, A, Emanuele, MJ, VprBP/DCAF1 Regulates the Degradation and Nonproteolytic Activation of the Cell Cycle Transcription Factor FoxM1. Mol Cell Biol, 2017, Jun 15; 37 (13): pii: e00609-16. PMID: 28416635
  42. Li, J, Liu, Q, Clark, LH, Qiu, H, Bae-Jump, VL^, Zhou, C, Deregulated miRNAs in human cervical cancer: functional importance and potential clinical use. Future Oncology, 2017, Apr; 13 (8):743-753. PMID: 27806630
  43. Wysham, WZ~, Roque, DR, Han, J, Zhang, L, Guo, H, Gehrig, PA, Zhou, C, Bae-Jump, VL#, Effects of Fatty Acid Synthase Inhibition by Orlistat on Proliferation of Endometrial Cancer Cell Lines. Target Oncol, 2016, Dec; 11 (6):763-769. PMID: 27188391
  44. Yuan L, Sheng X, Clark LH, Zhang L, Guo H, Jones HM, Willson AK, Gehrig PA, Zhou C, Bae-Jump, VL#, Glutaminase inhibitor compound 968 inhibits cell proliferation and sensitizes paclitaxel in ovarian cancer. Am J Transl Res, 2016, Oct 15; 8 (10):4265-4277. PMID: 27830010
  45. Qiu, H, Li, J, Clark, LH, Jackson, AL, Zhang, L, Guo, H, Kilgore, JE, Gehrig, PA, Zhou, C, Bae-Jump, VL#,  JQ1 suppresses tumor growth via PTEN/PI3K/AKT pathway in endometrial cancer. Oncotarget, 2016, Oct 11; 7 (41):66809-66821. PMID: 27572308
  46. Zhang,  JL, Han,  J, Jackson, AL, Clark, LN, Kilgore, J, Guo, H, Livingston, N, Batchelor, K, Yin, Y, Gilliam, TP, Gehrig, PA, Sheng, X, Zhou, C, Bae-Jump, VL#. NT1014, a novel biguanide, inhibits ovarian cancer growth in vitro and in vivo. Hematol Oncol., 2016, Sep 21; 9 (1):91. PMID: 27655410
  47. Suen, AA, Jefferson, WN, Wood, CE, Padilla-Banks, E, Bae-Jump, VL^, **, Williams, CJ, SIX1 Oncoprotein as a Biomarker in a Model of Hormonal Carcinogenesis and in Human Endometrial Cancer. Mol Cancer Res, 2016, Sep; 14 (9):849-58. PMID: 27259717
  48. Roque, DR~, Makowski, L, Chen, TH, Rashid, N, Hayes, DN and Bae-Jump, VL#, Association between differential gene expression and body mass index among endometrial cancers from The Cancer Genome Atlas Project. Gynecologic Oncology, 2016, Aug; 142 (2):317-22. PMID: 27288544
  49. Suri, A~, Sheng, X, Schuler, KM, Zhong, Y, Han, X, Jones, HM, Gehrig, PA, Zhou, C, Bae-Jump, VL#, The effect of celecoxib on tumor growth in ovarian cancer cells and a genetically engineered mouse model of serous ovarian cancer. Oncotarget, 2016, Jun 28; 7 (26):39582-39594. PMID: 27074576
  50. Kilgore, J~, Jackson, AL, Clark, LH, Guo, H, Zhang, L, Jones, HM, Gilliam, TP, Gehrig, PA, Zhou, C, Bae-Jump, VL#, Buformin exhibits anti-proliferative and anti-invasive effects in endometrial cancer cells. Am J Transl Res, 2016, Jun 15; 8 (6):2705-15. PMID: 27398153
  51. Guo, H, Zhong, Y, Jackson,  AL, Clark, LH, Kilgore, J, Zhang, L, Han, J, Sheng, X, Gilliam, TP, Gehrig, PA, Zhou, C, Bae-Jump, VL#, Everolimus exhibits anti-tumorigenic activity in obesity-induced ovarian cancer. Oncotarget, 2016, Apr 12; 7 (15):20338-56. PMID: 26959121
  52. Giovinazzo, H, Kumar, P, Sheikh, A, Brooks, KM, Ivanovic, M, Walsh, M, Caron, WP, Kowalsky, RJ, Song, G, Whitlow, A, Clarke-Pearson, DL, Brewster, WR, Van Le, L, Zamboni, BA, Bae-Jump, V^, Gehrig, PA, Zamboni, WC, Technetium Tc 99m sulfur colloid phenotypic probe for the pharmacokinetics and pharmacodynamics of PEGylated liposomal doxorubicin in women with ovarian cancer. Cancer Chemother Pharmacol, 2016, Mar; 77 (3):565-73. PMID: 26822231
  53. Clark, LH, Jackson, AL, Gehrig, PA, Bae-Jump, V^, Van Le, L, Ko, EM, Adjuvant Treatment and Clinical Trials in Elderly Patients With Endometrial Cancer: A Time for Change? Int J Gynecol Cancer, 2016, Feb; 26 (2):282-9. PMID: 26745698
  54. Clark, LH~, Ko, EM, Kernodle, A, Harris, A, Moore, DT, Gehrig, PA, Bae-Jump, VL#, Endometrial Cancer Survivors’ Perceptions of Provider Obesity Counseling and Attempted Behavior Change: Are We Seizing the Moment? Int J Gynecol Cancer, 2016, Feb; 26 (2):318-24. PMID: 26588234
  55. Secord, AA, Hasselblad, V, Von Gruenigen, VE, Gehrig, PA, Modesitt, SC, Bae-Jump, V^, Havrilesky, LJ, Body mass index and mortality in endometrial cancer: A systematic review and meta-analysis. Gynecol Oncol, 2016, Jan; 140 (1):184-90. PMID: 26524722
  56. Stine, JE~, Guo, H, Sheng, X, Han, X, Schointuch, MN, Gilliam, TP, Gehrig, PA, Zhou, C, Bae-Jump, VL#, The HMG-CoA reductase inhibitor, simvastatin, exhibits anti-metastatic and anti-tumorigenic effects in ovarian cancer. Oncotarget, 2016, Jan 5; 7 (1):946-60. PMID: 26503475
  57. Barber, EL, Boggess, JF, Van Le, L, Kim, KH, Bae-Jump, VL^, Brewster, WR, Soper, JT, Gehrig, PA, Association of Preoperative Thrombocytosis and Leukocytosis With Postoperative Morbidity and Mortality Among Patients With Ovarian Cancer. Obstet Gynecol, 2015, Dec; 126 (6):1191-7. PMID: 26551182
  58. Kong, W, Lv, N, Wysham, WZ, Roque, DR, Zhang, T, Jiao, S, Song, D, Chen, J, Bae-Jump, VL^, Zhou, C, Knockdown of hTERT and Treatment with BIBR1532 Inhibit Cell Proliferation and Invasion in Endometrial Cancer Cells. J Cancer, 2015, Nov 1; 6 (12):1337-45. PMID: 26640594
  59. Song, G, Tarrant, TK, White, TF, Barrow, DA, Santos, CM, Timoshchenko, RG, Hanna, SK, Ramanathan, RK, Lee, CR, Bae-Jump, VL^, Gehrig, PA, Zamboni, WC, Roles of Chemokines CCL2 and CCL5 in the Pharmacokinetics of PEGylated Liposomal Doxorubicin in Vivo and in Patients with Recurrent Epithelial Ovarian Cancer. Nanomedicine, 2015, Oct; 11 (7):1797-807. PMID: 26093057
  60. Han, J, Zhang, L, Guo, H, Wysham, WZ, Roque, DR, Willson, AK, Sheng, X, Zhou, C, Bae-Jump, VL#, Glucose promotes cell proliferation, glucose uptake and invasion in endometrial cancer cells via AMPK/mTOR/S6 and MAPK signaling. Gynecol Oncol, 2015, Sep; 138 (3):668-75. PMID: 26135947
  61. Yuan, L, Sheng, X, Wilson, AK, Roque, DR, Stine, JE, Jones, HM, Zhou, C, Bae-Jump, VL#, Glutamine promotes ovarian cancer cell proliferation through the mTOR/S6 pathway. Endocr Relat Cancer, 2015, Aug; 22 (4):577-91. PMID: 26045471
  62. Walker, JL, Powell, CB, Chen, LM, Carter, J, Bae-Jump, VL^, Parker, LP, Borowsky, ME, Gibb, RK, Society of Gynecologic Oncology recommendations for the prevention of ovarian cancer. Cancer, 2015, July; 121(13):2108-20. PMID: 25820366
  63. Landrum, LM, Blank, S, Chen, LM, Duska, L, Bae-Jump, V^, Lee, PS, Levine, L, McCourt, C, Moore, KN, Urban, RR, Comprehensive care in gynecologic oncology: The importance of palliative care.  Gynecol Oncol, 2015, May; 137 (2):  193-202. PMID:  25749723
  64. Blanco, I, Kuchenbaecker, K, Cuadras, D, Wang, X, Barrowdale, D, de Garibay, GR, Librado, P, Sanchez-Gracia, A, Rozas, J, Bonifaci, N, McGuffog, L, Pankratz, VS, Islam, A, Mateo, F, Berenguer, A, Petit, A, Catala, I, Brunet, J, Feliubadalo, L, Tornero, E, Benitez, J, Osorio, A, Ramon, y Cajal T, Nevanlinna, H, Aittomaki, K, Arun, BK, Toland, AE, Karlan, BY, Walsh, C, Lester, J, Greene, MH, Mai, PL, Nussbaum, RL, Andrulis, IL, Domchek, SM, Nathanson, KL, Rebbeck, TR, Barkardottir, RB, Jakubowska, A, Lubinski, J, Durda, K, Jaworska-Bieniek, K, Claes, K, Van Maerken, T, Diez, O, Hansen, TV, Jonson, L, Gerdes, AM, Ejlertsen, B, de la Hoya, M, Caldes, T, Dunning, AM, Oliver, C, Fineberg, E, Cook, M, Peock, S. McCann, E, Murray, A, Jacobs, C, Pichert, G. Lalloo, F, Chu, C, Dorkins, H, Paterson, J, Ong, KR, Teixeira, MR; Teixeira, Hogervorst, FB, van der Hout, AH, Seynaeve, C, van der Luijt, RB, Ligtenberg, MJ, Devilee, P, Wijnen, JT, Rookus, MA, Meijers-Heijboer, HE, Blok, MJ, van den Ouweland, AM, Aalfs, CM, Rodriguez, GC, Phillips, KA, Piedmonte, M, Nerenstone, SR, Bae-Jump, VL^, O’Malley, DM, Ratner, ES, Schmutzler, RK, Wappenschmidt, B, Rhiem, K, Engel, C, Meindl, A, Ditsch, N, Arnold, N, Plendl, HJ, Niederacher, D, Sutter, C, Wang-Gohrke S., Steinemann, D, Preisler-Adams, S, Kast, K, Varon-Mateeva, R, Gehrig, A, Bojesen, A, Pedersen, IS, Sunde, L, Jensen, UB, Thomassen, M, Kruse, TA, Foretova, L, Peterlongo, P, Bernard, L, Peissel, B, Scuvera, G, Manoukian, S, Radice, P, Ottini, L, Montagna, M, Agata, S, Maugard, C, Simard, J, Soucy, P, Berger, A, Fink-Retter, A, Singer, CF, Rappaport, C, Geschwantler-Kaulich, D, Tea, MK, Pfeiler, G; BCFR, John, EM, Miron, A, Neuhausen, SL, Terry, MB, Chung, WK, Daly, MB, Goldgar, DE, Janavicius, R, Dorfling, CM, van Rensburg, EJ, Fostira, F, Konstantopoulou, I, Garber, J, Godwin, AK, Olah, E, Narod, SA, Rennert, G, Paluch, SS, Laitman, Y, Friedman, E; SWE-BRCA, Liljegren, A, Rantala, J, Stenmark-Askmalm, M, Loman, N, Imyanitov, EN, Hamann, U; kConFab Investigators, Spurdle, AB, Healey, S, Weitzel, JN, Herzog, J, Margileth, D, Gorinni, C, Esteller, M, Gomez, A, Sayols, S, Vidal, E, Heyn, H; GEMO, Stoppa-Lyonnet, D, Leone, M, Barjhoux, L, Fassy-Colcombet, M, de Pauw, A, Lasset, C, Ferrer, SF, Castera, L, Berthet, P, Cornelis, F, Bignon, YJ, Damiola, F, Mazoyer, S, Sinilnikova, OM, Maxwell, CA, Vijai, J, Robson, M, Kauff, N. Corines, MJ, Villano, D, Cunningham, J, Lee, A, Lindor, N, Lazaro, C, Easton, DF, Offit, K, Chenevix-Trench, G, Couch, FJ, Antoniou, AC, Pujana, MA, Assessing associations between the AURKA-HMMR-TPX2-TUBG1 functional module and breast cancer risk in BRCA ½ mutation carriers. PLoS One, 2015, Apr 1; 10(4):e0120020. PMID: 25830658
  65. Qiu, H, Jackson, AL, Kilgore, JE, Zhong, Y, Chan, LL, Gehrig, PA, Zhou, C, Bae-Jump, VL#, JQ1 suppresses tumor growth through downregulating LDHA in ovarian cancer. Oncotarget, 2015, Mar 30; 6 (9):6915-30.  PMID: 25762632
  66. Nair, SV, Witek, MA, Jackson, JM, Lindell, MA, Hunsucker, SA, Sapp, T, Perry, CE, Hupert, ML, Bae-Jump, V^, Gehrig PA, Wysham WZ, Armistead PM, Voorhees P, Soper SA, Enzymatic cleavage of uracil-containing single-stranded DNA linkers for the efficient release of affinity-selected circulating tumor cells. Chem Commun (Camb), 2015, Feb 5; 51 (15):3266-9. PMID: 25616078
  67. Schuler, KM~, Rambally, BS, Difurio, MJ, Sampey, BP, Gehrig, PA, Makowski, L and Bae-Jump, VL#, Anti-proliferative and metabolic effects of metformin in a pre-operative window clinical trial for endometrial cancer, Cancer Medicine, 2015, Feb;4(2):161-73. PMID: 25417601
  68. Doll, KM, Kalinowski, AK, Snavely, AC, Irwin, DE, Bensen, JT, Bae-Jump, VL^, Kim, KH, Van Le, L, Clarke-Pearson, DL, Gehrig, PA, Obesity is associated with worse quality of life in women with gynecologic malignancies: An opportunity to improve patient-centered outcomes. Cancer, 2015, Feb 1;121(3):395-402. PMID: 25250951
  69. Ko, EM, Stürmer, T, Hong, JL, Castillo, WC, Bae-Jump, V^, Funk, MJ, Metformin and the risk of endometrial cancer: A population-based cohort study, Gynecol Oncol, 2015, Feb; 136 (2):341-7. PMID: 25499603
  70. Han, X, Sheng X, Jones, HM, Jackson, AL, Kilgore, J, Stine, JE, Schointuch, MN, Zhou C, Bae-Jump, VL#, Evaluation of the anti-tumor effects of lactate dehydrogenase inhibitor galloflavin in endometrial cancer cells. J Hematol Oncol. 2015, Jan 29; 8 (1):2. PMID: 25631326
  71. Wang, J, Ma, X, Jones, HM, Chan, L, Song, F, Zhang, W, Bae-Jump, VL^, Zhou, C, Evaluation of the antitumor effects of c-Myc-Max heterodimerization inhibitor 100258-F4 in ovarian cancer cells. J Transl Med, 2014, Aug 21; 12 (1):226. PMID: 25143136
  72. Stine, JE~ and Bae-Jump, VL#, Metformin and gynecologic cancers. Obstet Gynecol Surv, 2014, Aug; 69 (8):477-89. PMID:25144611
  73. Schointuch, MN‡, Gilliam, TP, Stine, JE, Han, X, Zhou, C, Gehrig, PA, Kim, K and Bae-Jump, VL#, Simvastatin an HMG-CoA reductase inhibitor, exhibits anti-metastatic and anti-tumorigenic effects in endometrial cancer, Gynecol Oncol, 2014, Aug; 134 (2):346-55. PMID: 24880141
  74. Doll, KM, Snavely, AC, Kalinowski, A, Irwin, DE, Bensen, JT, Bae-Jump, V^, Boggess, JF, Soper, JT, Brewster, WR, Gehrig, PA, Preoperative quality of life and surgical outcomes in gynecologic oncology patients: A new predictor of operative risk? Gynecol Oncol, 2014, Jun; 133 (3): 546-51. PMID: 24726615
  75. Previs, R, Kilgore, J, Craven, R, Broadwater, G, Bean, S, Wobker, S, DiFurio, M, Bae-Jump, V^, Gehrig, PA and Secord, AA, Obesity is associated with worse overall survival in women with low grade papillary serous epithelial ovarian cancer. Int J of Gynecol Cancer, 2014, May; 24 (4):670-5. PMID: 24614825
  76. Makowski, L, Zhou, C, Zhong, Y, Kuan, PF, Fan, Sampey, BP, Difurio, M and Bae-Jump, VL#, Obesity increases tumor aggressiveness in a genetically engineered mouse model of serous ovarian cancer. Gynecol Oncol, 2014, Apr; 133 (1):90-7. PMID: 24680597
  77. Ko, EM~, Walter, P, Clark, L, Jackson, A, Franasiak, J, Bolac, C, Havrilesky, L, Secord, AA, Moore, DT, Gehrig, PA and Bae-Jump, VL#, The complex triad of obesity, diabetes and race in Type I and II endometrial cancers: Prevalence and prognostic significance. Gynecol Oncol, 2014, Apr; 133 (1):28-32. PMID: 24680588
  78. Ko, EM~, Walter, P, Jackson, A, Clark, L, Franasiak, J, Bolac, C, Havrilesky, LJ, Secord, AA, Moore, DT, Gehrig, PA and Bae-Jump, V#, Metformin is associated with improved survival in endometrial cancer. Gynecol Oncol, 2014, Feb; 132 (2):438-42. PMID: 24269517
  79. Caron, WP, Lay, JC, Fong, AM, La-Beck, NM, Kumar, P, Newman, SE, Zhou, H, Monaco, JH, Clarke-Pearson, DL, Brewster, WR, Van Le, L, Bae-Jump, VL^, Gehrig, PA and Zamboni, WC, Translational Studies of Phenotypic Probes for the Mononuclear Phagocyte System and Liposomal Pharmacology.  J. Pharmacol Exp Ther, 2013 Dec; 347 (3):599-606.  PMID: 24042160
  80. Doll, KM, Stine, JE, Van Le, L, Moore, DT, Bae-Jump, V^, Brewster, WR, Soper, JT, Boggess, JF, Gehrig, PA, Kim, KH, Outpatient end of life discussions shorten hospital admissions in gynecologic oncology patients. Gynecol Oncol, 2013, Jul; 130 (1):152-5. PMID: 23542684
  81. Hubbs, JL, Saig, RM, Abaid, LN, Bae-Jump, VL^ and Gehrig, PA, Systemic Compared With Local Therapy for Hormone Treatment of Endometrial Hyperplasia and Early Adenocarcinoma. Obstet Gynecol, 2013, Jun; 121 (6): 1172-80. PMID: 23812449
  82. Couch, FJ, Wang, X, McGuffog L, Lee, A, Olswold, C, Kuchenbaecker, KB, Soucy, P, Fredericksen, Z, Barrowdale, D, Dennis, J, Gaudet, MM, Dicks, E, Kosel, M, Healey, S, Sinilnikova, OM, Lee, A, Bacot, F, Vincent, D, Hogervorst, FB, Peock, S, Stoppa-Lyonnet, D, Jakubowska, A; kConFab Investigators, Radice, P, Schmutzler, RK; SWE-BRCA, Domchek, SM, Piedmonte, M, Singer, CF, Friedman, E, Thomassen, M; Ontario Cancer Genetics Network, Hansen TV, Neuhausen, SL, Szabo, CI, Blanco, I, Greene, MH, Karlan, BY, Garber, J, Phelan, CM, Weitzel, JN, Montagna, M, Olah, E, Andrulis, IL, Godwin, AK, Yannoukakos, D, Goldgar, DE, Caldes, T, Nevanlinna, H, Osorio, A, Terry, MB, Daly, MB, van Rensburg, EJ, Hamann, U, Ramus, SJ, Toland, AE, Caligo, MA, Olopade, OI, Tung, N, Claes, K, Beattie, MS, Southey, MC, Imyanitov, EN, Tischkowitz, M, Janavicius, R, John, EM, Kwong, A, Diez, O, Balmaña, J, Barkardottir, RB, Arun, BK, Rennert, G, Teo, SH, Ganz, PA, Campbell, I, van, der Hout, AH, van Deurzen, CH, Seynaeve, C, Gómez Garcia, EB, van Leeuwen, FE, Meijers-Heijboer, HE, Gille, JJ, Ausems, MG, Blok, MJ, Ligtenberg, MJ, Rookus, MA, Devilee, P, Verhoef, S, van Os, TA, Wijnen, JT; HEBON; EMBRACE, Frost, D, Ellis, S, Fineberg, E, Platte, R, Evans, DG, Izatt, L, Eeles, RA, Adlard, J, Eccles, DM, Cook, J, Brewer, C, Douglas, F, Hodgson, S, Morrison, PJ, Side, LE, Donaldson, A, Houghton, C, Rogers, MT, Dorkins, H, Eason, J, Gregory, H, McCann, E, Murray, A, Calender, A, Hardouin, A, Berthet, P, Delnatte, C, Nogues, C, Lasset, C, Houdayer, C, Leroux, D, Rouleau, E, Prieur, F, Damiola, F, Sobol, H, Coupier, I, Venat-Bouvet, L, Castera, L, Gauthier-Villars, M, Léoné, M, Pujol, P, Mazoyer, S, Bignon, YJ; GEMO Study Collaborators, Złowocka-Perłowska, E, Gronwald, J, Lubinski, J, Durda, K, Jaworska, K, Huzarski, T, Spurdle, AB, Viel, A, Peissel, B, Bonanni, B, Melloni, G, Ottini, L, Papi, L, Varesco, L, Tibiletti, MG, Peterlongo, P, Volorio, S, Manoukian, S, Pensotti, V, Arnold, N, Engel, C, Deissler, H, Gadzicki, D, Gehrig, A, Kast, K, Rhiem, K, Meindl, A, Niederacher, D, Ditsch, N, Plendl, H, Preisler-Adams, S, Engert, S, Sutter, C, Varon-Mateeva, R, Wappenschmidt, B, Weber, BH, Arver, B, Stenmark-Askmalm, M, Loman, N, Rosenquist, R, Einbeigi, Z, Nathanson, KL, Rebbeck, TR, Blank, SV, Cohn, DE, Rodriguez, GC, Small, L, Friedlander, M, Bae-Jump, VL^, Fink-Retter, A, Rappaport, C, Gschwantler-Kaulich, D, Pfeiler, G, Tea, MK, Lindor, NM, Kaufman, B, Shimon, Paluch, S, Laitman, Y, Skytte, AB, Gerdes, AM, Pedersen, IS, Moeller, ST, Kruse, TA, Jensen, UB, Vijai, J, Sarrel, K, Robson, M, Kauff, N, Mulligan, AM, Glendon, G, Ozcelik, H, Ejlertsen, B, Nielsen, FC, Jønson, L, Andersen, MK, Ding, YC, Steele, L, Foretova, L, Teulé, A, Lazaro, C, Brunet, J, Pujana, MA, Mai, PL, Loud, JT, Walsh, C, Lester, J, Orsulic, S, Narod, SA, Herzog, J, Sand, SR, Tognazzo, S, Agata, S, Vaszko, T, Weaver, J, Stavropoulou, AV, Buys, SS, Romero, A, de la Hoya, M, Aittomäki, K, Muranen, TA, Duran, M, Chung, WK, Lasa, A, Dorfling, CM, Miron, A; BCFR, Benitez, J, Senter, L, Huo, D, Chan, SB, Sokolenko, AP, Chiquette, J, Tihomirova, L, Friebel, TM, Agnarsson, BA, Lu, KH, Lejbkowicz, F, James, PA, Hall, P, Dunning, AM, Tessier, D, Cunningham, J, Slager, SL, Wang, C, Hart, S, Stevens K, Simard, J, Pastinen, T, Pankratz, VS, Offit, K, Easton, DF, Chenevix-Trench, G, Antoniou, AC, CIMBA, Genome-wide association study in BRCA1 mutation carriers identifies novel loci associated with breast and ovarian cancer risk. PLoS Genet, 2013, Mar: 9(3): e1003212. PMID: 23544013
  83. Zhou, C, Steplowski, TA, Dickens, HK, Malloy, KM, Gehrig, PA, Boggess, JF and Bae-Jump, VL#, Estrogen induction of telomerase activity through regulation of the Mitogen-Activated Protein Kinase (MAPK) dependent pathway in human endometrial cancer cells. PLos One, 2013, Feb: 8 (2): e55730. PMID: 23409030
  84. Bae-Jump, V^, Jazaeri, A, Summary of the 2012 American Association for Cancer Research (AACR) Annual Meeting. Gynecol Oncol, 2012, Aug; 126 (2): 174-5. PMID: 22588179
  85. Hanna, RK~, Zhou, C, Malloy, KM, Sun, L, Zhong, Y, Gehrig, PA, Bae-Jump, VL#, Metformin potentiates the effects of paclitaxel in endometrial cancer cells through inhibition of cell proliferation and modulation of the mTOR pathway. Gynecol Oncol, 2012, May; 125 (2):458-69. PMID: 22252099
  86. Mendivil, A~, Zhou, C, Cantrell, LA, Gehrig, PA, Malloy, KM, Blok, LJ, Burger, CW, Bae-Jump, VL#, AMG 479, a novel IGF-1-R antibody, inhibits endometrial cancer cell proliferation through disruption of the PI3K/Akt and MAPK pathways. Reprod Sci, 2011, Sep; 18 (9):832-41. PMID: 21846689
  87. Van Le, L, Ko, E, Gehrig, P, Difurio, M, Bae-Jump, VL^, Rossi, E, Discussion: ‘Tumor diameter as a predictor in endometrial cancer surgery’ by Yanazume et al. Am J Obstet Gynecol, 2011, Jun; 204 (6):e1-3. PMID: 21752746
  88. Bae-Jump, VL*, Zhou, C, Boggess, JF, Whang, YE, Barroilhet, L, Gehrig, PA, Rapamycin inhibits cell proliferation in type I and type II endometrial carcinomas: A search for biomarkers of sensitivity to treatment. Gynecol Oncol, 2010, Dec; 119 (3):579-85. PMID: 20863555
  89. Shafer, A~, Zhou, C, Gehrig, PA, Boggess, JF, Bae-Jump, VL#, Rapamycin potentiates the effects of paclitaxel in endometrial cancer cells through inhibition of cell proliferation and induction of apoptosis. Int J Cancer, 2010, Mar 1; 126 (5):1144-54. PMID: 19688827
  90. Gehrig, PA, Bae-Jump, VL^, Promising novel therapies for the treatment of endometrial cancer. Gynecol Oncol, 2010, Feb; 116 (2):187-94. PMID: 19903572
  91. Cantrell, LA~, Mendivil, A, Malloy, KM, Zhou, C, Gehrig, PA, Bae-Jump, VL#, Metformin is a potent inhibitor of endometrial cancer cell proliferation – implications for a novel treatment strategy. Gynecol Oncol, 2010, Jan; 116 (1):92-8. PMID: 19822355
  92. Bae-Jump, VL*, Zhou, C, Boggess, JF, Gehrig, PA, Synergistic Effect of Rapamycin and Cisplatin in Endometrial Cancer Cells. Cancer, 2009, Sep 1; 115 (17):3887-96. PMID: 19484784
  93. Secord, AA, Havrilesky, LJ, O’Malley, DM, Bae-Jump, V^, Fleming, ND, Broadwater, G, Cohn, DE, Gehrig, PA, A multicenter evaluation of sequential multimodality therapy and clinical outcome for the treatment of advanced endometrial cancer. Gynecol Oncol, 2009, Sep;114(3):442-7. PMID: 19560193
  94. Havrilesky, LJ, Secord, AA, O’Malley, DM, Broadwater, G, Bae-Jump, V^, Cohn, DE, Gehrig, PA. Multicenter analysis of recurrence and survival in stage IIIA endometrial cancer. Gynecol Oncol. 2009 Aug; 114 (2):279-83. PMID: 19446319
  95. Alvarez Secord, A, Bae-Jump, VL^, Havrilesky, LJ, Calingaert, B, Clarke-Pearson, DL, Soper, JT, Gehrig, PA, Attitudes regarding the use of hematopoietic colony-stimulating factors and maintenance of relative dose intensity among gynecologic oncologists. Int J Gynecol Cancer, 2009, Apr; 19 (3):447-54. PMID: 19407573
  96. Bae-Jump, VL*, Zhou, C, Boggess, JF, Gehrig, PA, Arsenic trioxide (As2O3) inhibits expression of estrogen receptor-alpha through regulation of the mitogen-activated protein kinase (MAPK) pathway in endometrial cancer cells. Reprod Sci, 2008, Dec; 15 (10):1011-7. PMID: 19088370
  97. Alvarez Secord, A, Havrilesky, LJ, Bae-Jump, VL^, Chin, J, Calingaert, B, Bland, A, Rutledge, TL, Berchuck, A, Clarke-Pearson, DL, Gehrig, PA, The role of multi-modality adjuvant chemotherapy and radiation in women with advanced stage endometrial cancer. Gynecol Oncol, 2007, Nov; 107 (2):285-91. PMID: 17688923
  98. Havrilesky, LJ, Alvarez-Secord, AA, Bae-Jump, VL^, Ayeni, T, Calingaert, B, Clarke-Pearson, DL, Berchuck, A, Gehrig, PA, Outcomes in surgical stage I uterine papillary serous carcinoma. Gynecol Oncol, 2007, Jun; 105 (3):677-82. PMID: 17355889
  99. Zhou, C, Boggess, JF, Bae-Jump, VL^, Gehrig, PA, Induction of apoptosis and inhibtion of telomerase activity by arsenic trioxide (AS2O3) in endometrial carcinoma cells. Gynecol Oncol, 2007, Apr; 105 (1):218-22. PMID: 17275888
  100. Bae-Jump, VL*, Bauer, M, Van Le, L, Cytologic Evaluation Correlates Poorly with Histologic Diagnosis of Vulvar Neoplasias. J Low Genit Tract Dis, 2007, Jan; 11 (1):8-11. PMID: 17194944
  101. Boggess, JF, Zhou, C, Bae-Jump, VL^, Gehrig, PA, Whang, YE, Estrogen receptor dependent regulation of telomerase activity in human endometrial cancer cell lines. Gynecol Oncol, 2006, Nov; 103 (2):417-24. PMID: 16690106
  102. Zhou, C, Bae-Jump, VL^, Whang, YE, Gehrig, PA, Boggess, JF, The PTEN tumor suppressor inhibits telomerase activity in endometrial cancer cells by decreasing hTERT mRNA level. Gynecol Oncol, 2006, May; 101 (2):305-10. PMID: 16380156
  103. Bae-Jump, VL*, Zhou, C, Gehrig, PA, Whang, YE, Boggess, JF, Rapamycin inhibits hTERT telomerase mRNA expression, independent of cell cycle arrest. Gynecol Oncol, 2006, Mar; 100 (3):487-94. PMID: 16249016
  104. Boruta, DM 2nd, Gehrig, PA, Groben, PA, Bae-Jump, V^, Boggess, JF, Fowler, WC Jr., Van Le, L, Uterine serous and grade 3 endometrioid carcinomas: Is there a survival difference? Cancer, 2004, Nov 15; 101 (10):2214-21. PMID: 15452833
  105. Gehrig, PA, Bae-Jump, VL^, Boggess, JF, Groben, PA, Fowler, WC Jr., Van Le, L, Association between uterine serous carcinoma and breast cancer. Gynecol Oncol, 2004, Jul; 94 (1):208-11. PMID: 15262144
  106. Kauma, SW, Bae-Jump, V^, Walsh, SW, Hepatocyte growth factor stimulates trophoblast invasion: a potential mechanism for abnormal placentation in preeclampsia. J Clin Endocrinol Metab, 1999, Nov; 84 (11):4092-6. PMID: 10566655
  107. Bae-Jump, V*, Segreti, EM, Vandermolen, D, Kauma, SW, Hepatocyte growth factor (HGF) induces invasion of endometrial carcinoma cell lines in vitro. Gynecol Oncol, 1999, May; 73 (2):265-72. PMID: 10329045
  108. Bae, VL*, Jackson-Cook, CK, Maygarden, SJ, Plymate, SR, Chen, J, Ware, JL, Metastatic sublines of an SV40 large T antigen immortalized human prostate epithelial cell line. Prostate, 1998, Mar 1; 34 (4):275-82. PMID: 9496902
  109. Plymate, SS, Bae, VL^, Maddison, L, Quinn, LS, Ware, JL, Type-1 insulin-like growth factor receptor re-expression in the malignant phenotype of SV40-T immortalized human prostate epithelial cells enhance apoptosis. Endocrine, 1997, Aug; 7 (1):119-24. PMID: 9449047
  110. Plymate, SR, Bae, VL^, Maddison, L, Quinn, LS, Ware, JL. Re-expression of the type 1 insulin-like growth factor receptor inhibits the malignant phenotype of simian virus 40 T antigen immortalized human prostate epithelial cells. Endocrinology. 1997 Apr; 138 (4):1728-35. PMID: 9075737
  111. Jackson-Cook, CK, Bae, VL^, Edleman, W, Brothman, AR, Chen, J, Ware, JL, Cytogenetic characterization of the human prostate cancer cell line P69SV40T and its novel tumorigenic sublines M2182 and M15. Cancer Genet Cytogenet, 1996, Mar; 87 (1):14-23. PMID: 8646734
  112. Maygarden, SJ, Novotny, DB, Moul, JW, Bae, VL^, Ware, JL, Evaluation of cathepsin D and epidermal growth factor receptor in prostate carcinoma. Mod Pathol, 1994, Dec; 7(9):930-6. PMID: 7892162
  113. Bae, VL*, Jackson-Cook, CK, Brothman, AR, Maygarden, SJ, Ware, JL, Tumorigenicity of SV40T antigen immortalized human prostate epithelial cells: association with decreased epidermal growth factor receptor (EGFR) expression. Int J Cancer, 1994, Sep 1; 58 (5):721-9. PMID: 8077059